↓ Skip to main content

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales

Overview of attention for article published in Frontiers in Pharmacology, January 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
4 news outlets
twitter
15 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
242 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
Published in
Frontiers in Pharmacology, January 2022
DOI 10.3389/fphar.2021.807548
Pubmed ID
Authors

Amelia D. Dahlén, Giovanna Dashi, Ivan Maslov, Misty M. Attwood, Jörgen Jonsson, Vladimir Trukhan, Helgi B. Schiöth

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 242 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 242 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 9%
Researcher 18 7%
Student > Bachelor 16 7%
Student > Master 14 6%
Student > Postgraduate 9 4%
Other 29 12%
Unknown 134 55%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 9%
Pharmacology, Toxicology and Pharmaceutical Science 20 8%
Medicine and Dentistry 16 7%
Chemistry 11 5%
Agricultural and Biological Sciences 9 4%
Other 26 11%
Unknown 139 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2023.
All research outputs
#1,171,485
of 25,721,020 outputs
Outputs from Frontiers in Pharmacology
#445
of 19,995 outputs
Outputs of similar age
#29,100
of 518,476 outputs
Outputs of similar age from Frontiers in Pharmacology
#20
of 1,162 outputs
Altmetric has tracked 25,721,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,995 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 518,476 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 1,162 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.